|NextSeq 550 System||RNA分析：每次运行6–20个样本（基于每个样本2000万条read）||2 x 75 bp|
|NextSeq 550 System||转录组分析：每次运行2–8个样本（基于每个样本5000万条read）||2 x 75 bp|
|HiSeq 2500 System||RNA分析：每次运行30–200个样本（双流动槽；基于每个样本2000万条read）||2 x 75 bp|
|HiSeq 2500 System||转录组分析：每次运行12–80个样本（双流动槽；基于每个样本5000万条read）||2 x 75 bp|
|NovaSeq 6000 System||RNA分析（每次运行的样本，双流动槽）：S1：160，S2：320，S4：768。受标签组合的限制（双重）。基于2000万条read。||≤ 2 × 100 bp|
|NovaSeq 6000 System||转录组分析（每次运行的样本，双流动槽）：S1：64，S2：128，S4：400。受标签组合的限制（双重）。基于5000万条read。||≤ 2 × 100 bp|
Limited Use Label License: The TruSeq Stranded Total RNA with Ribo-Zero Plant Workflow product and its use are the subject of one or more issued and/or pending U.S. and foreign patent applications owned by Max Planck Gesellschaft, exclusively licensed to New England Biolabs, Inc. and sublicensed to Illumina, Inc. The purchase of this product from Illumina, Inc., its affiliates, or its authorized resellers and distributors conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product by the buyer (whether the buyer is an academic or for profit entity). The purchase of this product does not convey a license under any claims in the foregoing patents or patent applications direct to producing the product. The buyer cannot sell or otherwise transfer this product or its components to a third party or otherwise use the product for the following COMMERCIAL PURPOSES: (I) use of the product or its components in manufacturing; or (2) use of the product or its components for therapeutic or prophylactic purposes in human or animals.